We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automatic Blood Cell Analyzer Detects Malaria Parasites

By LabMedica International staff writers
Posted on 15 Dec 2011
An automated hematology analyzer can detect malaria parasites during routine complete blood counts.

The analyzer can sensitively detect and accurately monitor an infection of Plasmodium vivax in blood samples, as well as being an effective screening test for the parasite.

Scientists at the Catholic University of Korea (Seoul, Korea) retrospectively analyzed a total of 1,761 complete blood count (CBC) samples generated by the automated hematology analyzer. More...
The sample pool contained 123 samples from 52 P. vivax malaria patients and 1,504 nonmalarial samples including 509 patients with leucopenia whose white blood cell count was less than 2,000/μL, and 134 normal subjects.

The P. vivax malaria samples exhibited easily recognizable typical malaria signals on the nucleated red blood cell (nRBC) plots with a sensitivity of 100% using the automatic blood cell analyzer, the DxH 800. All 1,504 samples without P. vivax infection were negative for malaria signal giving a specificity of 100%. The size of P. vivax malaria signals correlated approximately with the parasite burden.

The gold standard of P. vivax-malaria diagnosis is the microscopy of blood smears. Although microscopy is a rapid, cost-effective, and readily applicable method, it has many disadvantages, including low sensitivity, specificity, and precision. Therefore, there is a clear need for an effective screening test for P. vivax-malaria detection in both high-prevalence areas and developed countries.

The automated hematology analyzer DxH 800 (Beckman Coulter Inc., Miami, FL, USA) provided very sensitive and specific, easily recognizable P. vivax-malaria signals on routine CBC without need for the additional reagents or special procedures. The study was published online on November 11, 2011, in the International Journal of Laboratory Hematology.

Related Links:
Catholic University of Korea
Beckman Coulter Inc.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Urine Analyzer
respons® UDS100
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.